{
  "ticker": "LLY",
  "target_date": "2025-06-04",
  "actual_date": "2025-06-04",
  "collected_at": "2025-12-08T11:50:59.134117",
  "price": {
    "open": 753.63,
    "high": 769.8,
    "low": 753.24,
    "close": 763.041015625,
    "volume": 3135900,
    "change_1d_pct": 2.01,
    "change_7d_pct": 7.3,
    "change_30d_pct": -7.27
  },
  "technicals": {
    "rsi_14": 67.16,
    "sma_20": 736.52,
    "sma_50": 774.63,
    "macd": -12.577,
    "macd_signal": -18.115,
    "macd_histogram": 5.538,
    "bb_upper": 772.59,
    "bb_lower": 700.46,
    "price_vs_sma20_pct": 3.6,
    "price_vs_sma50_pct": -1.5,
    "volume_ratio": 0.71
  },
  "fundamentals": {
    "market_cap": 891795210240,
    "pe_ratio": 48.740814,
    "forward_pe": 43.901146,
    "price_to_book": 37.45482,
    "price_to_sales": 15.008385,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.54,
    "pct_from_52w_low": 59.48
  },
  "macro": {
    "spy": {
      "price": 592.53,
      "change_1d_pct": -0.03,
      "change_7d_pct": 0.81
    },
    "vix": {
      "level": 17.61,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.36
    },
    "dollar_index": {
      "level": 98.79
    },
    "gold": {
      "price": 3373.5
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Chase Coleman's Tiger Global Portfolio - Q1 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1749060979,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=8217a9dbdb18eab5bb49b18cb25b3d9333ec2d370d12cfc46ea85bde2345c119"
    },
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1749054660,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=86bdcbcf65276422d6848385690a99e783281a02db70fc3197872e6f05282c82"
    },
    {
      "headline": "Lilly partners with Camurus in search of a long-lasting obesity drug",
      "source": "Yahoo",
      "datetime": 1749034860,
      "summary": "The deal, which could be worth up to $870 million overall, will give Lilly access to a delivery technology that may help extend the durability of up to four of its weight-loss medicines.",
      "url": "https://finnhub.io/api/news?id=5378e2360480579a9d8c77eb753ca90fd6ba1891017f276ce325cb7a6e50b4a4"
    },
    {
      "headline": "Welldoc Says Working With Lilly To Launch Personalized Health & Medicine Platform",
      "source": "Finnhub",
      "datetime": 1749033008,
      "summary": "Welldoc: * WELLDOC: WORKING WITH LILLY TO LAUNCH A NEW PERSONALIZEDHEALTH& MEDICINE PLATFORM FOR THOSE PRESCRIBED LILLY'S INCRETINTHERAPIESSource text:Further company coverage: ...",
      "url": "https://finnhub.io/api/news?id=b6bf77685e786d956bcba3f8fee75f685d50aa4b6294a45eb3c1000045a0a41e"
    },
    {
      "headline": "1 Underrated Reason to Buy This Market-Beating Stock",
      "source": "Yahoo",
      "datetime": 1749032100,
      "summary": "Eli Lilly recently acquired a smaller biotech for its promising investigational pain medication.  The company generates strong sales from products outside of diabetes and obesity care.  Eli Lilly's portfolio, both within and outside its core area, makes the stock attractive.",
      "url": "https://finnhub.io/api/news?id=db48df7a17c18eaf4702eaa028f26078f83e5f2a1a041ce4d146f35eef17101c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-27",
      "description": "xslF345X05/wk-form4_1748376794.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}